Pediatric Drugs: More Illness, But Less Research

Kermit Cole
0
55

An international team of researchers identified all drug trials registered in ClinicalTrials.gov between 2006 and 2011 and tracked the resulting publications, finding that although 60% of the disease burden was attributable to children, only 12% of trials were pediatric. This may be, the authors say, a product of pediatric trials’ greater reliance on governmental and nonprofit funding (60%), in contrast to adult trials’ 65% reliance on industry funding.  Results appeared in Pediatrics, online July 23, 2012.

Abstract → Bourgeois, F., Murthy, S., “Pediatric Versus Adult Drug Trials for Conditions With High Pediatric Disease Burden” Pediatrics, online July 23, 2012 (doi: 10.1542/peds.2012-0139)

Related Item:
How Psych Drug Studies Shortchange Kids

Previous articleHappiness and First-Episode Schizophrenia
Next articlePsychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and their Families 
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]

LEAVE A REPLY